Autopsy report · NCT04176016

Phase I Study of Radiolabeled OTSA101-DTPA in Patients With Relapsed or Refractory Synovial Sarcoma

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Some of the raw materials for the investigational drug are difficult to obtain and expensive.”

The sponsor’s own words in the registry.

Life of this trial

Registered 2 months before it started.
Ran for about 4 years before it stopped.
12 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 1
Sponsor: OncoTherapy Science, Inc.
Sponsor type: Industry
Conditions: Relapsed or Refractory Synovial Sarcoma
Interventions: OTSA101-DTPA-111In; OTSA101-DTPA-90Y
Participants: 12
Sites: 3
Countries: Japan

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.